Racura Oncology LtdASX: RAC

RC220 MYC-silencing data to be presented FCS 26 conference

Sep 7, 2026 at 7:15 PM EDT · Issued by Racura Oncology Ltd via ASX

Filed with ASX · Sep 7, 2026 at 7:15 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/rc220-myc-silencing-data-to-be-presented-fcs-26-conference

Release

Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3043 | info@racuraoncology.com | www.racuraoncology.com 1 ASX Announcement Racura RC220 MYC-silencing data to be presented at the 2026 Frontiers in Cancer Science Conference § Poster presentation...

Racura Oncology Ltd on 6ix

Story so far

Racura presents MYC silencing data at AACR 2026Apr 22, 2026

Earlier from Racura Oncology

Racura Oncology Adelaide Investor BriefingSep 3
Notification regarding unquoted securities - RACAug 31
CPACS Trial Opens for RC220 Patient Enrolment in KoreaAug 31
Corporate Governance StatementAug 25
Appendix 4GAug 25

Later from Racura Oncology

Appendix 3Y - Dr Daniel TillettSep 22
Date of AGM & Closing Date for Director NominationsOct 4
Racura Presents CPACS Data at GCOS 2026Oct 6
HARNESS-1 First Cohort ClearedOct 11
Sept 2026 Quarterly Activities Report and Appendix 4COct 21

All Racura Oncology news releases

Follow Racura Oncology into a list and get an email when it puts out news.

Follow Racura Oncology